Skip to main content
. Author manuscript; available in PMC: 2018 Mar 5.
Published in final edited form as: Leukemia. 2016 Aug 29;31(3):625–636. doi: 10.1038/leu.2016.243

Figure 3.

Figure 3

BLIMP-1 protein expression in DLBCL. (a) Representative immunohistochemical stains of DLBCL sections for BLIMP-1 protein expression. (b) The histograms of BLIMP-1 protein expression in all DLBCL patients, and the distribution of PRDM1 deletions and mutations and BLIMP-1 protein expression in 180 patients with all these three data available. Expression of miR-30d-3p and miR-30b-5p was elevated in BLIMP-1− DLBCL patients without PRDM1 genetic alterations. (c) The impact of BLIMP-1 protein expression on OS and PFS in DLBCL patients with mutated TP53.